Princeton Alpha Management’s Biogen BIIB Stock Holding History

Princeton Alpha Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-4,212	Closed	-$1.15M	–	58
2017 Q1	$1.15M	Sell	4,212 -3,135	-43%	-$886K	0.39%	55
2016 Q4	$2.08M	Buy	7,347 +2,347	+47%	+$696K	0.43%	35
2016 Q3	$1.56M	Sell	5,000 -4,876	-49%	-$1.44M	0.29%	75
2016 Q2	$2.39M	Buy	+9,876	New	+$2.6M	0.43%	32
2016 Q1	–	Sell	-6,102	Closed	-$1.87M	–	733
2015 Q4	$1.87M	Buy	6,102 +4,817	+375%	+$1.38M	0.32%	85
2015 Q3	$375K	Buy	1,285 +769	+149%	+$254K	0.08%	392
2015 Q2	$208K	Sell	516 -390	-43%	-$157K	0.04%	585
2015 Q1	$383K	Buy	+906	New	+$357K	0.08%	344
2014 Q4	–	Sell	-1,348	Closed	-$446K	–	676
2014 Q3	$446K	Buy	1,348 +708	+111%	+$233K	0.1%	288
2014 Q2	$202K	Sell	640 -343	-35%	-$103K	0.04%	578
2014 Q1	$301K	Sell	983 -345	-26%	-$110K	0.09%	342
2013 Q4	$371K	Buy	+1,328	New	+$343K	0.27%	121

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Princeton Alpha Management's BIIB Position: Q2 2017 in Review

Princeton Alpha Management sold out of Biogen (BIIB) in Q2 2017, closing a stake of 4,212 shares — an estimated $1.15M sold.

Princeton Alpha Management first reported a position in BIIB in Q4 2013 and held it in 12 quarters. The position peaked at $2.39M in Q2 2016. 992 funds tracked by Wall St. Rank hold BIIB as of Q2 2017.

Princeton Alpha Management reported no remaining Biogen position as of Q2 2017 after selling out during the quarter.
Princeton Alpha Management sold 4,212 Biogen shares in Q2 2017, an estimated $1.15M.
Princeton Alpha Management first reported a position in Biogen in Q4 2013 and held it in 12 quarters.
Princeton Alpha Management's Biogen position peaked at $2.39M in Q2 2016.
992 funds tracked by Wall St. Rank held Biogen as of Q2 2017.

Based on Princeton Alpha Management's 13F filing for Q2 2017.